best performing small cap stocks march 3, 2017 to march 20 2017

Aurinia Pharmaceuticals (AUPH) had the highest return between March 3, 2017 and March 20, 2017 by a small-cap US stock, returning 86.8%.

ASSET DATE % RETURN
Aurinia Pharmaceuticals (AUPH)
3/3/2017 - 3/20/2017
86.81%
TSS, Inc Common Stock (TSSI)
3/3/2017 - 3/20/2017
73.64%
Microvision (MVIS)
3/3/2017 - 3/20/2017
68.83%
Clearpoint Neuro (CLPT)
3/3/2017 - 3/20/2017
60%
Pulse Biosciences (PLSE)
3/3/2017 - 3/20/2017
57.63%
Corvus Pharmaceuticals (CRVS)
3/3/2017 - 3/20/2017
52%
Nektar Therapeutics (NKTR)
3/3/2017 - 3/20/2017
49.09%
Verastem (VSTM)
3/3/2017 - 3/20/2017
42.11%
Esperion Therapeutics (ESPR)
3/3/2017 - 3/20/2017
37.4%
Hello (MOMO)
3/3/2017 - 3/20/2017
30.23%
CytomX Therapeutics (CTMX)
3/3/2017 - 3/20/2017
30.1%
Spyre Therapeutics (SYRE)
3/3/2017 - 3/20/2017
29.94%
United States Antimony (UAMY)
3/3/2017 - 3/20/2017
28.95%
Arbutus Biopharma (ABUS)
3/3/2017 - 3/20/2017
28.85%
Lincoln Educational Services (LINC)
3/3/2017 - 3/20/2017
27.49%
Galectin Therapeutics (GALT)
3/3/2017 - 3/20/2017
26.35%
Maui Land & Pineapple (MLP)
3/3/2017 - 3/20/2017
24.47%
Astria Therapeutics (ATXS)
3/3/2017 - 3/20/2017
23.93%
BioCryst Pharmaceuticals (BCRX)
3/3/2017 - 3/20/2017
23.66%
Himax Technologies (HIMX)
3/3/2017 - 3/20/2017
23.43%
Assembly Biosciences (ASMB)
3/3/2017 - 3/20/2017
22.13%
Regenxbio (RGNX)
3/3/2017 - 3/20/2017
21.72%
Safe Bulkers (SB)
3/3/2017 - 3/20/2017
20.78%
PowerFleet (AIOT)
3/3/2017 - 3/20/2017
20.69%
AnaptysBio (ANAB)
3/3/2017 - 3/20/2017
19.09%
Small-cap stocks are treated as having a market cap between $300M and $2B.